Literature DB >> 17447048

[Secondary prevention after urological cancers. What are the pertinent facts about aftercare?].

A Schroeder1.   

Abstract

Secondary prevention and aftercare of urological cancers are an essential part of outpatient care provided by the urologist in private practice. More than one-half of the patients who are confronted with the diagnosis of cancer turn to so-called unconventional treatment procedures. The difficulties for those affected and caregivers lie in equal measure in distinguishing between sensible and less advisable or even counterproductive treatment options. Fixed plans of action for aftercare do not do justice to the exigencies of individualized care of cancer patients in private practice, especially with respect to longer survival. Early detection of local recurrence and metastases and the management of complications are determined by the individual disease course and have to be measured against the improvement in quality of life. Secondary preventive measures in the sense of complementary medicine can be helpful. Current evidence is quite promising only for prostate cancer and is of some importance in urological practice.

Entities:  

Mesh:

Year:  2007        PMID: 17447048     DOI: 10.1007/s00120-007-1343-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  5 in total

Review 1.  How useful are unconventional cancer treatments?

Authors:  E Ernst; B R Cassileth
Journal:  Eur J Cancer       Date:  1999-10       Impact factor: 9.162

2.  [Evaluation of the complementary drug Factor AF2 as a supportive agent in management of advanced urothelial carcinoma. Prospective randomized multicenter study].

Authors:  S Krege; A Hinke; T Otto; H Rübben
Journal:  Urologe A       Date:  2002-03       Impact factor: 0.639

3.  Selenium and immunocompetence in patients with head and neck cancer.

Authors:  L Kiremidjian-Schumacher; M Roy; R Glickman; K Schneider; S Rothstein; J Cooper; H Hochster; M Kim; R Newman
Journal:  Biol Trace Elem Res       Date:  2000-02       Impact factor: 3.738

4.  Advising patients who seek complementary and alternative medical therapies for cancer.

Authors:  Wendy A Weiger; Michael Smith; Heather Boon; Mary Ann Richardson; Ted J Kaptchuk; David M Eisenberg
Journal:  Ann Intern Med       Date:  2002-12-03       Impact factor: 25.391

Review 5.  Assessment and management of cancer-related fatigue in adults.

Authors:  Karin Ahlberg; Tor Ekman; Fannie Gaston-Johansson; Victoria Mock
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.